Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: a real‐world investigation

I Rosenstein, S Rasch, M Axelsson… - Journal of …, 2021 - Wiley Online Library
Kappa free light chain (KFLC) index, a measure for intrathecal production of free kappa
chains, has been increasingly recognized for its diagnostic potential in multiple sclerosis …

Kappa free light chains: Diagnostic performance in multiple sclerosis and utility in a clinical laboratory

DA Martins, J Lopes, AM da Silva, CI Morais… - Clinica Chimica …, 2022 - Elsevier
Background Automated, technically simple analytical methods offering objective results are
highly valued in clinical laboratories. Kappa free light chains (KFLC) in cerebrospinal fluid …

Kappa free light chain biomarkers are efficient for the diagnosis of multiple sclerosis: a large multicenter cohort study

M Levraut, S Laurent-Chabalier… - Neurology …, 2022 - AAN Enterprises
Background and Objectives Kappa free light chains (KFLC) seem to efficiently diagnose MS.
However, extensive cohort studies are lacking to establish consensus cut-offs, notably to …

Evaluation of kappa index as a tool in the diagnosis of multiple sclerosis: implementation in routine screening procedure

CT Sanz Diaz, S de las Heras Flórez… - Frontiers in …, 2021 - frontiersin.org
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous
system. Previous studies have shown that cerebrospinal fluid (CSF) kappa free light chains …

Intrathecal kappa free light chains as markers for multiple sclerosis

D Vecchio, G Bellomo, R Serino, E Virgilio… - Scientific Reports, 2020 - nature.com
Cerebrospinal fluid (CSF) kappa free light chain (KFLC) index has been described as a
reliable marker of intrathecal IgG synthesis to diagnose multiple sclerosis (MS). Our aims …

Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: a multicenter study

S Presslauer, D Milosavljevic, W Huebl… - Multiple Sclerosis …, 2016 - journals.sagepub.com
Background: Kappa free light chains (KFLCs) have been proposed as a diagnostic
biomarker in patients with clinically isolated syndrome (CIS) and multiple sclerosis (MS) …

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

CE Leurs, HAM Twaalfhoven… - Multiple Sclerosis …, 2020 - journals.sagepub.com
Objective: To validate kappa free light chain (KFLC) and lambda free light chain (LFLC)
indices as a diagnostic biomarker in multiple sclerosis (MS). Methods: We performed a …

The increasing role of kappa free light chains in the diagnosis of multiple sclerosis

FF Konen, P Schwenkenbecher, KF Jendretzky… - Cells, 2021 - mdpi.com
Free light chains (FLC) are a promising biomarker to detect intrathecal inflammation in
patients with inflammatory central nervous system (CNS) diseases, including multiple …

Kappa free light chains in cerebrospinal fluid in inflammatory and non-inflammatory neurological diseases

FF Konen, P Schwenkenbecher, KF Jendretzky… - Brain Sciences, 2022 - mdpi.com
Background: Oligoclonal bands represent intrathecal immunoglobulin G (IgG) synthesis and
play an important role in the diagnosis of multiple sclerosis (MS). Kappa free light chains …

Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—From diagnosis to prediction of disease activity

H Hegen, K Berek, F Deisenhammer - Wiener Medizinische Wochenschrift, 2022 - Springer
Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system
that shows a high interindividual heterogeneity, which frequently poses challenges …